Barclays analyst Lauren Lieberman lowered the firm’s price target on Brown-Forman (BF.B) to $31 from $38 and keeps an Overweight rating on the shares. The company’s fiscal 2026 guidance for a low-single-digit decline on organic sales and operating profit came in well below market expectations, the analyst tells investors in a research note. The firm says the outlook will add fuel to the “already lively” structural versus cyclical debate around beverage alcohol. However, Barclays believes there was little from Brown-Forman’s update to suggest the weakness is a result of a permanent change in consumer demand.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BF.B:
- Brown-Forman downgraded to Neutral from Outperform at BNP Paribas Exane
- Brown-Forman Reports Fiscal 2025 Earnings Amid Challenges
- Brown-Forman Stock (BF.B) Crashes 18% after Alcohol Giant Warns of Tariff Risks
- Trump-Xi call focuses on trade, PVH reports Q2 beat: Morning Buzz
- Morning Movers: Brown-Forman plummets following fourth quarter results
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue